At a glance

ClinicalIndex Comparison Record

N/ACompleted· 45 enrolled

Drug / intervention

measurementother

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02896543

NCT02896543N/ACompleted

Compare CT.gov

The Relationship of Change of Dendritic Cells Fractalkine and P-selectin in Patients With Acute Myocardial Infarction

The First Affiliated Hospital of Dalian Medical University·observational·Posted Sep 12, 2016·Updated Aug 1, 2017

In Brief

An observational study evaluating measurement for Acute Myocardial Infarction. Completed, enrolled 45 participants across 1 site.

Detailed Summary

This study evaluates the relationship of change of dendritic cells fractalkine and P-selectin in patients with acute myocardial infarction.

Study Details

Study Typeobservational

Allocation--

Masking--

Primary Purpose--

ConditionsAcute Myocardial Infarction

CountriesChina

Collaborators--

Timeline

N/ACompletedFinished

2017201820192020202120222023202420252026

Enrollment StartSep 2016

First PostedSep 2016

Primary CompletionJan 2017

Study CompletionMar 2017

TodayJul 2026

First PostedSep 12, 2016

Enrollment StartSep 1, 2016

Primary CompletionJan 1, 2017

Study CompletionMar 1, 2017

TodayJul 2, 2026

Enrollment to primary: 4 monthsPosted 9.8 years ago

Interventions

measurementother

Blood is obtained into ethylene diamine tetraacetic acid（EDTA） tubes from all subjects via antecubital vein puncture to measure the number of dendritic cells(DCs) and the concentration of sP-selectin. The number of dendritic cells(DCs) and the concentration of sP-selectin are measured in all patients with STEMI at 0 and 5-7 days after admission. The number of dendritic cells(DCs) and the only once in control group after admission.